Copyright
©The Author(s) 2017.
World J Clin Oncol. Apr 10, 2017; 8(2): 151-157
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.151
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.151
Age (yr) | Total number of nodules | Gender | All FNAs (n = 124) n, % | |||||
F/M | Bethesda I | Bethesda II | Bethesda III | Bethesda IV | Bethesda V | Bethesda VI | ||
15-30 | 18 (14.5) | 3/15 | 0 | 3 | 1 | 3 | 4 | 7 |
31-45 | 49 (39.5) | 39/10 | 1 | 5 | 2 | 9 | 7 | 25 |
46-60 | 43 (34.7) | 35/8 | 1 | 7 | 3 | 9 | 5 | 18 |
61-75 | 12 (9.7) | 8/4 | 0 | 1 | 0 | 3 | 2 | 6 |
> 75 | 2 (1.6) | 2/0 | 0 | 0 | 0 | 1 | 0 | 1 |
Total | 124 | 87/37 | 2 (1.6) | 16 (12.9) | 6 (4.8) | 25 (20.2) | 18 (14.5) | 57 (46) |
- Citation: Al Dawish MA, Robert AA, Muna A, Eyad A, Al Ghamdi A, Al Hajeri K, Thabet MA, Braham R. Bethesda System for Reporting Thyroid Cytopathology: A three-year study at a tertiary care referral center in Saudi Arabia. World J Clin Oncol 2017; 8(2): 151-157
- URL: https://www.wjgnet.com/2218-4333/full/v8/i2/151.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i2.151